Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bio-Techne Corp (NASDAQ:TECH)

106.16
Delayed Data
As of 2:29pm ET
 +1.06 / +1.01%
Today’s Change
79.95
Today|||52-Week Range
114.56
+17.96%
Year-to-Date
TrovaGene (TROV) Q1 Loss Wider than Expected, Stock Gains
May 11 / Zacks.com - Paid Partner Content
Bio-Techne (TECH): Moving Average Crossover Alert
May 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close105.10
Today’s open105.63
Day’s range104.68 - 106.63
Volume151,707
Average volume (3 months)240,167
Market cap$3.9B
Dividend yield1.21%
Data as of 2:29pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)-3.67%
Earnings growth (this year)+6.62%
Earnings growth (next 5 years)+12.50%
Revenue growth (last year)+26.41%
P/E ratio37.7
Price/Sales8.11
Price/Book4.61

Competitors

 Today’s
change
Today’s
% change
ALRAlere Inc+0.37+0.91%
NEOGNeogen Corp+1.48+3.08%
AAAPAdvanced Accelerator...-0.52-1.83%
GHDXGenomic Health Inc+1.21+4.75%
Data as of 2:29pm ET, 05/24/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$0.95
Annual revenue (last year)$452.2M
Annual profit (last year)$107.7M
Net profit margin23.82%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles R. Kummeth
CFO, VP-Finance &
Chief Accounting Officer
James T. Hippel
Corporate headquarters
Minneapolis, Minnesota

Forecasts

Partner Offers

Search for Jobs